Correction: First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma [J Transl Med., 16, (2018) (142)] DOI: 10.1186/s12967-018-1507-6
Research output: Contribution to specialist publication › Corrections (errata and retractions) › peer-review
Contributors
Abstract
Following publication of the original article [1], the authors reported an error in the spelling of one of the author names. In this Correction the incorrect and correct author names are indicated and the author name has been updated in the original publication. The authors also reported an error in the Methods section of the original article. In this Correction the incorrect and correct versions of the affected sentence are indicated. The original article has not been updated with regards to the error in the Methods section.
Details
Original language | English |
---|---|
Pages | 179 |
Volume | 16 |
Issue number | 1 |
Journal | Journal of translational medicine |
Publication status | Published - 29 Jun 2018 |
Peer-reviewed | Yes |
No renderer: customAssociatesEventsRenderPortal,dk.atira.pure.api.shared.model.researchoutput.ContributionToPeriodical
External IDs
PubMed | 29958537 |
---|